XML 33 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Non-Current Assets
12 Months Ended
Dec. 31, 2024
Non-current Assets  
Non-Current Assets

7. Non-Current Assets

 

As at December 31, 2024, the Company had non-current assets of $0.4 million, which comprised clinical trial deposits held by a contract research organization in relation to the Company’s Phase 1/2 clinical trials. As at December 31, 2023, the Company had non-current assets of $1.3 million, which was wholly attributable to clinical trial deposits.